AT-0174

N/A

Report date: 2025/01/26 17:28:38

NME

Base Information

Drug NameAT-0174

Drug Alias Namedual IDO checkpoint inhibitor/TDO checkpoint inhibitor (Antido Therapeutics/University of Miami)Treg modulator (Antido Therapeutics/University of Miami)AT-0174

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTryptophan 2,3-dioxygenase inhibitorsIndoleamine 2,3-dioxygenase inhibitors

TargetsIndoleamine 2,3-dioxygenaseTryptophan 2,3-dioxygenase

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Miami

China Registration ClassN/A

Develop Information

Active CompaniesAntido Therapeutics (Australia) Pty Ltd

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell Lung

Inactive IndicationsN/A

Other Information

ATC CodeN/A